Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirius latency, triggering p53-mediated apoptosis in transformed B lymphocytes

被引:94
作者
Curreli, F
Friedman-Kien, AE
Flore, O
机构
[1] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA
关键词
D O I
10.1172/JCI200523334
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Kaposi sarcoma-associated herpesvirus (KSHV) is linked with all clinical forms of Kaposi sarcoma and several lymphoproliferative disorders. Like other herpesviruses, KSHV becomes latent in the infected cells, expressing only a few genes that are essential for the establishment and maintenance of its latency and for the survival of the infected cells. Inhibiting the expression of these latent genes should lead to eradication of herpesvirus infection. All currently available drugs are ineffective against latent infection. Here we show, for the first time to our knowledge, that latent infection with KSHV in B lymphocytes can be terminated by glycyrrhizic acid (GA), a triterpenoid compound earlier shown to inhibit the lytic replication of other herpesviruses. We demonstrate that GA disrupts latent KSHV infection by downregulating the expression of latency-associated nuclear antigen (LANA) and upregulating the expression of viral cyclin and selectively, induces cell death of KSHV-infected cells. We show that reduced levels of LANA lead to p53 reactivation, an increase in ROS, and mitochondrial dysfunction, which result in G, cell cycle arrest, DNA fragmentation, and oxidative stress-mediated apoptosis. Latent genes are involved in KSHV-induced oncogenesis, and strategies to interfere with their expression might prove useful for eradicating latent KSHV infection and have future therapeutic implications.
引用
收藏
页码:642 / 652
页数:11
相关论文
共 52 条
[1]  
Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO
[2]  
2-B
[3]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[4]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[5]  
BATES S, 1994, ONCOGENE, V9, P1633
[6]  
Bélanger C, 2001, J HUMAN VIROL, V4, P62
[7]   Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis [J].
Bertin, J ;
Armstrong, RC ;
Ottilie, S ;
Martin, DA ;
Wang, Y ;
Banks, S ;
Wang, GH ;
Senkevich, TG ;
Alnemri, ES ;
Moss, B ;
Lenardo, MJ ;
Tomaselli, KJ ;
Cohen, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1172-1176
[8]   Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site [J].
Bieleski, L ;
Talbot, SJ .
JOURNAL OF VIROLOGY, 2001, 75 (04) :1864-1869
[9]   Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice [J].
Boshoff, C ;
Gao, SJ ;
Healy, LE ;
Matthews, S ;
Thomas, AJ ;
Coignet, L ;
Warnke, RA ;
Strauchen, JA ;
Matutes, E ;
Kamel, OW ;
Moore, PS ;
Weiss, RA ;
Chang, Y .
BLOOD, 1998, 91 (05) :1671-1679
[10]   IN-VITRO ESTABLISHMENT AND CHARACTERIZATION OF 2 ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LYMPHOMA CELL-LINES (BC-1 AND BC-2) CONTAINING KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE (KSHV) DNA-SEQUENCES [J].
CESARMAN, E ;
MOORE, PS ;
RAO, PH ;
INGHIRAMI, G ;
KNOWLES, DM ;
CHANG, Y .
BLOOD, 1995, 86 (07) :2708-2714